Has Kathryn Thompson, PA received payments from drug or device companies?

Yes. Drug and device makers reported $7,099 in general payments to Kathryn Thompson, PA across 348 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Kathryn Thompson, PA did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Kathryn Thompson, PA come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Kathryn Thompson, PA

Physician Assistant · Greenville, TXNPI 1003182130

Payments from drug & device makers

$7,099in general payments, 2019–2025

Across 348 payments — averaging $20.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$1K
Amgen$730
AstraZeneca$549
Myriad Genetic Laboratories, Inc.$440
Arcutis Biotherapeutics, Inc.$397
Seagen Inc.$315
plus $3K from 40 others

What the payments were for

Food & beverage$7,099100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	42	$1,311
Amgen	40	$730
AstraZeneca(2 entities)	29	$549
Myriad Genetic Laboratories, Inc.	12	$440
Arcutis Biotherapeutics, Inc.	44	$397
Seagen Inc.	17	$315
Merck	13	$292
Novartis	14	$285
Pharmacyclics LLC, An Abbvie Company	16	$269
E.r. Squibb & Sons, L.L.C.	16	$238
Regeneron Healthcare Solutions, Inc.	8	$203
Bristol Myers Squibb	13	$199
Exelixis Inc.	7	$187
Incyte Corporation	9	$179
Eisai Inc.	7	$124
Beigene USA, Inc.	5	$121
LEO Pharma Inc.	1	$109
GSK	3	$98
Coherus Oncology, Inc.	5	$86
Bayer	4	$74
Sun Pharmaceutical Industries Inc.	2	$74
Karyopharm Therapeutics Inc.	3	$64
AMAG Pharmaceuticals, Inc.	2	$62
Gilead(2 entities)	3	$59
Genentech USA, Inc.	3	$55
Astellas Pharma US Inc	2	$43
Daiichi Sankyo Inc.	2	$40
AVEO Pharmaceuticals, Inc.	2	$39
Johnson & Johnson	2	$35
Puma Biotechnology, Inc.	2	$32
EUSA Pharma (US) LLC	2	$32
Blueprint Medicines Corporation	1	$31
Sanofi	2	$31
Pfizer	1	$30
Tempus AI, Inc	1	$30
Array Biopharma Inc	1	$27
Deciphera Pharmaceuticals Inc.	2	$27
Sobi, Inc	2	$27
Pharmacosmos Therapeutics Inc.	1	$25
Mylan Institutional Inc.	1	$25
EMD Serono, Inc.	1	$22
UCB, Inc.	1	$21
Takeda Pharmaceuticals U.S.A., Inc.	1	$17
Stemline Therapeutics Inc.	1	$16
Morphosys, US Inc.	1	$16
Rigel Pharmaceuticals, Inc.	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

myRisk$231
Rinvoq$224
Elahere$136
ANZUPGO$109

How this compares

$7,099 in reported general payments places this provider in the 90th percentile of 8,308 physician assistant providers in Texas.

See all physician assistant providers in Texas →

Medicare billing

Part B allowed, 2024

$45,145

Medicare patients

134

Services billed

1,434

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Estradiol	20	$2,286
Dexamethasone	22	$531
Lidocaine-PrilocaineLidocaine/Prilocaine	31	$332
Prochlorperazine Maleate	14	$174
Gabapentin	12	$109
Pantoprazole Sodium	14	$66
Potassium Chloride	13	$23

Paid to pharmacies, not to this prescriber.

Other physician assistant in Greenville

Cynthia TrickettDallas$1.3M
Kristine KuceraMelissa$797K
Selina SantosAustin$543K
Matthew BrunoMcKinney$538K
Anthony DerenciusSan Antonio$507K
Brooke HodnickSouthlake$479K
Holly GloverArlington$418K
Kirk GautierAthens$416K
Jaime RomanPlano$338K
Michael WhiteDallas$276K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →